Morrisville, NC – According to filings with the U.S. Securities and Exchange Commission, Clinipace is raising $14,716,442.00 in new funding. Sources indicate as part of senior management Chief Financial Officer, Mark Ubert played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Clinipace

At Clinipace, a global, full-service contract research organization, our approach to clinical research is personal. We deliver a level of collaboration and flexibility not possible in a traditional CRO environment. With personalized services and solutions, local regulatory expertise and therapeutic leadership, we overcome the most difficult industry challenges across all major therapeutic areas including oncology, gastroenterology, nephrology and urology, rare disease, and women’s health. We strive to improve the way clinical research is performed and impact the future of health care using the most advanced technology and a CHALLENGE ACCEPTED approach.

To learn more about Clinipace, visit http://www.clinipace.com/

Contact:
Mark Ubert, Chief Financial Officer
919-224-8800
markubert@clinipace.com

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved